Cutera (NASDAQ:CUTR) Releases Quarterly Earnings Results, Beats Expectations By $0.23 EPS

Cutera (NASDAQ:CUTR) posted its quarterly earnings data on Thursday. The medical device company reported $0.15 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.08) by $0.23, reports. The company had revenue of $46.12 million during the quarter, compared to analyst estimates of $41.66 million. Cutera had a negative net margin of 20.49% and a negative return on equity of 69.92%. The company’s revenue was up 13.7% on a year-over-year basis. During the same quarter last year, the business posted $0.11 earnings per share.

Shares of CUTR traded up $3.75 during mid-day trading on Friday, hitting $36.28. 764,700 shares of the company traded hands, compared to its average volume of 170,393. Cutera has a one year low of $12.32 and a one year high of $38.88. The company has a current ratio of 1.67, a quick ratio of 1.16 and a debt-to-equity ratio of 0.18. The business has a 50-day moving average of $30.12 and a 200 day moving average of $24.67. The stock has a market capitalization of $466.84 million, a price-to-earnings ratio of -16.27 and a beta of 0.88.

Several analysts have recently weighed in on the stock. Zacks Investment Research raised shares of Cutera from a “hold” rating to a “buy” rating and set a $35.00 price objective for the company in a report on Tuesday, October 29th. ValuEngine raised shares of Cutera from a “hold” rating to a “buy” rating in a report on Friday, November 1st. Maxim Group reissued a “hold” rating on shares of Cutera in a research note on Friday, August 9th. Sidoti cut shares of Cutera from a “buy” rating to a “neutral” rating in a research note on Thursday, August 22nd. Finally, BidaskClub raised shares of Cutera from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, November 5th. Two analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $40.00.

About Cutera

Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.

Featured Article: What are some reasons analysts would give stocks a buy rating?

Earnings History for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with's FREE daily email newsletter.